HHS Essential Health Benefits Should Establish "Protected" Drug Classes, As In Part D, BIO Says
This article was originally published in The Pink Sheet Daily
Executive Summary
BIO advises HHS officials in an Oct. 25 "listening session" that the essential health benefits regulations for private insurance plans should incorporate a number of Medicare Part D formulary policies - except the one that allows use of specialty tiers.